[HTML] sciencedirect.com

[HTML][HTML] Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma

MD Taussig, MEI Koran, SK Mouli, A Ahmad… - HPB, 2017 - Elsevier
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …
被引用次数：28 相关文章
[HTML] hpbonline.org

[HTML][HTML] Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma

MD Taussig, MEI Koran, SK Mouli, A Ahmad… - HPB, 2017 - hpbonline.org
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma

MD Taussig, MEI Koran, SK Mouli, A Ahmad… - HPB, 2017 - hpbonline.org
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma

MD Taussig, MEI Koran, SK Mouli… - HPB: the official …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma

MD Taussig, MEI Koran, SK Mouli, A Ahmad… - HPB, 2017 - scholars.northwestern.edu
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma.

MD Taussig, IK ME, SK Mouli, A Ahmad… - HPB: the Official …, 2017 - europepmc.org
Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …